43
35
Growth Score 43 in past quarter
-35 pts
Heat Score 35 in past quarter
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
525313
PrimeGen US develops novel therapies using the stemXcell platform to cure inflammatory diseases at the cellular level.
Acquired by 
DT Cloud Star Acquisition Corp
About the Company
PrimeGen US operates in the biotechnology industry, focusing on the development of novel therapies. The company utilizes an agile model to create clinical-grade, FDA-approved stem cells. PrimeGen US has developed the stemXcell platform, which aids in the discovery of key cytokines, proteins, and other agents necessary for activating or preparing
cells. The company's goal is to cure inflammatory diseases naturally at the cellular level.